Advertisement

---

THE LEUKEMIA & LYMPHOMA SOCIETY

EHE International and The Leukemia & Lymphoma Society Showcase Advances in Blood Cancer Research and Patient Access in the Heart of Manhattan

[2013-07-01] -


The Leukemia & Lymphoma Society and Johns Hopkins University School of Medicine to Collaborate on a Phase II Clinical Trial to Advance Innovative Immunotherapy for Multiple Myeloma Patients

[2013-07-01] -


Gilles B. Legault, Transportation and Supply Chain Lawyer For CN, Elected to The Leukemia & Lymphoma Society National Board of Directors

[2013-06-27] -


Ralph E. Lawson, Baptist Health Executive, Elected to The Leukemia & Lymphoma Society National Board of Directors

[2013-06-27] -


/C O R R E C T I O N -- The Leukemia & Lymphoma Society/

[2013-06-27] -


Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients

[2013-06-19] - -TNT Fuels 300 New Research Programs to Discover Breakthrough Treatments& Cures-


The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities

[2013-06-06] - Partnership Seeks to Accelerate Development of Innovative Therapies


The Leukemia & Lymphoma Society Applauds FDA's Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma

[2013-06-05] -


The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients

[2013-05-22] - Anti-CD20-Interferon Alpha Fusion Protein (IGN002) is a promising drug candidate for NHL patients who are resistant to standard therapy


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers